The risk or severity of adverse effects can be increased when valsartan is combined with Salsalate.


The risk or severity of adverse effects can be increased when Rosuvastatin is combined with DAPTOMYCIN.


The risk or severity of adverse effects can be increased when valsartan is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when oxazepam is combined with dibucaine.


The risk or severity of adverse effects can be increased when ethosuximide is combined with levodopa.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when loxapine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when propofol is combined with triflupromazine.


The risk or severity of adverse effects can be increased when triazolam is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when apraclonidine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when chloroquine is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when loxapine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Conivaptan is combined with sotalol.


The risk or severity of adverse effects can be increased when temazepam is combined with meperidine.


The risk or severity of adverse effects can be increased when temazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with brimonidine.


The risk or severity of adverse effects can be increased when valsartan is combined with timolol.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Nabilone.


The risk or severity of adverse effects can be increased when tropicamide is combined with orphenadrine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when valsartan is combined with irbesartan.


The risk or severity of adverse effects can be increased when ambenonium is combined with nicotine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with SIMEPREVIR.


The risk or severity of adverse effects can be increased when mecamylamine is combined with morphine.


The risk or severity of adverse effects can be increased when zopiclone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with desipramine.


The risk or severity of adverse effects can be increased when zopiclone is combined with amitriptyline.


The risk or severity of adverse effects can be increased when buspirone is combined with chlormezanone.


The risk or severity of adverse effects can be increased when valsartan is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when sumatriptan is combined with naratriptan.


The risk or severity of adverse effects can be increased when sumatriptan is combined with rizatriptan.


The risk or severity of adverse effects can be increased when moclobemide is combined with clomipramine.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with enoxacin.


The risk or severity of adverse effects can be increased when sulindac is combined with ibuprofen.


The risk or severity of adverse effects can be increased when floctafenine is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when Miltefosine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Asenapine.


The risk or severity of adverse effects can be increased when sulpiride is combined with ethosuximide.


The risk or severity of adverse effects can be increased when phenobarbital is combined with clemastine.


The risk or severity of adverse effects can be increased when codeine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with benzocaine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when codeine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when morniflumate is combined with diclofenac.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with vigabatrin.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Etomidate is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with dibucaine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with doxazosin.


The risk or severity of adverse effects can be increased when captopril is combined with leflunomide.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when etizolam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with labetalol.


The risk or severity of adverse effects can be increased when Ciclesonide is combined with ambenonium.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with tizanidine.


The risk or severity of adverse effects can be increased when topiramate is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when midazolam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when sevoflurane is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when midazolam is combined with thiopental.


The risk or severity of adverse effects can be increased when tubocurarine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when clorazepate is combined with cocaine.


The risk or severity of adverse effects can be increased when clorazepate is combined with ondansetron.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when propranolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when olanzapine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Darunavir is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when tizanidine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Telaprevir is combined with oxycodone.


The risk or severity of adverse effects can be increased when clorazepate is combined with zonisamide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with etizolam.


The risk or severity of adverse effects can be increased when procaine is combined with Halazepam.


The risk or severity of adverse effects can be increased when phenytoin is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when procaine is combined with proparacaine.


The risk or severity of adverse effects can be increased when cilazapril is combined with fenbufen.


The risk or severity of adverse effects can be increased when isoflurane is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when propofol is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Melatonin is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with nisoldipine.


The risk or severity of adverse effects can be increased when biperiden is combined with propoxyphene.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with edrophonium.


The risk or severity of adverse effects can be increased when propofol is combined with enalapril.


The risk or severity of adverse effects can be increased when pentobarbital is combined with lithium ion.


The risk or severity of adverse effects can be increased when amisulpride is combined with clonazepam.


The risk or severity of adverse effects can be increased when amisulpride is combined with promethazine.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Butethal.


The risk or severity of adverse effects can be increased when pentobarbital is combined with amobarbital.


The risk or severity of adverse effects can be increased when gemcitabine is combined with clozapine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when nicergoline is combined with pravastatin.


The risk or severity of adverse effects can be increased when oxprenolol is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when clozapine is combined with butalbital.


The risk or severity of adverse effects can be increased when gabapentin is combined with felbamate.


The risk or severity of adverse effects can be increased when amiodarone is combined with methazolamide.


The risk or severity of adverse effects can be increased when nitrazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when triazolam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when zopiclone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Telmisartan is combined with hydralazine.


The risk or severity of adverse effects can be increased when Camazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when prazosin is combined with doxazosin.


The risk or severity of adverse effects can be increased when mecamylamine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with desipramine.


The risk or severity of adverse effects can be increased when tioconazole is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when clonidine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when reserpine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when olanzapine is combined with isoflurane.


The risk or severity of adverse effects can be increased when salicylic acid is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when dyclonine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Masoprocol.


The risk or severity of adverse effects can be increased when reserpine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with etizolam.


The risk or severity of adverse effects can be increased when methysergide is combined with Delavirdine.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with efavirenz.


The risk or severity of adverse effects can be increased when celecoxib is combined with fluocinonide.


The risk or severity of adverse effects can be increased when quinapril is combined with tolmetin.


The risk or severity of adverse effects can be increased when atenolol is combined with lisinopril.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with fosinopril.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with tiapride.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ketorolac is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when methysergide is combined with amprenavir.


The risk or severity of adverse effects can be increased when oxazepam is combined with Etidocaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with ethotoin.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with butorphanol.


The risk or severity of adverse effects can be increased when Etomidate is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Etomidate is combined with levodopa.


The risk or severity of adverse effects can be increased when Rufinamide is combined with proparacaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when bromazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Halazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when lisinopril is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when flurazepam is combined with Paliperidone.


The risk or severity of adverse effects can be increased when nicergoline is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when nalbuphine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when thalidomide is combined with nefazodone.


The risk or severity of adverse effects can be increased when argatroban is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when nicergoline is combined with SAQUINAVIR.


The risk or severity of adverse effects can be increased when nalbuphine is combined with phenobarbital.


The risk or severity of adverse effects can be increased when Masoprocol is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with isoflurane.


The risk or severity of adverse effects can be increased when nalbuphine is combined with moclobemide.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with benzocaine.


The risk or severity of adverse effects can be increased when selegiline is combined with ritodrine.


The risk or severity of adverse effects can be increased when morphine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with tizanidine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when triflupromazine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with proparacaine.


The risk or severity of adverse effects can be increased when perphenazine is combined with clonidine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when estazolam is combined with ethotoin.


The risk or severity of adverse effects can be increased when haloperidol is combined with zotepine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Halazepam.


The risk or severity of adverse effects can be increased when ondansetron is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with Demecarium.


The risk or severity of adverse effects can be increased when Tramadol is combined with gabapentin.


The risk or severity of adverse effects can be increased when tenoxicam is combined with flunisolide.


The risk or severity of adverse effects can be increased when ramipril is combined with timolol.


The risk or severity of adverse effects can be increased when nalbuphine is combined with indapamide.


The risk or severity of adverse effects can be increased when enflurane is combined with Retigabine.


The risk or severity of adverse effects can be increased when Halazepam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when cetirizine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Carbetocin.


The risk or severity of adverse effects can be increased when lorazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with lansoprazole.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Mometasone.


The risk or severity of adverse effects can be increased when methyldopa is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with protriptyline.


The risk or severity of adverse effects can be increased when nicergoline is combined with fluvastatin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with cetirizine.


The risk or severity of adverse effects can be increased when pentazocine is combined with zaleplon.


The risk or severity of adverse effects can be increased when pentazocine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Eplerenone.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with methazolamide.


The risk or severity of adverse effects can be increased when alprazolam is combined with pentazocine.


The risk or severity of adverse effects can be increased when benazepril is combined with Pregabalin.


The risk or severity of adverse effects can be increased when alprazolam is combined with trazodone.


The risk or severity of adverse effects can be increased when meclizine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with nitrendipine.


The risk or severity of adverse effects can be increased when halothane is combined with tizanidine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with aspirin.


The risk or severity of adverse effects can be increased when halothane is combined with furosemide.


The risk or severity of adverse effects can be increased when halothane is combined with phentolamine.


The risk or severity of adverse effects can be increased when flurazepam is combined with halothane.


The risk or severity of adverse effects can be increased when halothane is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when bromazepam is combined with Iloperidone.


The risk or severity of adverse effects can be increased when butalbital is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when lorazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with phenylephrine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when Mometasone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when isradipine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with morphine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with methyldopa.


The risk or severity of adverse effects can be increased when Melatonin is combined with fexofenadine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Tramadol is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when meperidine is combined with oxycodone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Pramocaine.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Benidipine.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Nabilone.


The risk or severity of adverse effects can be increased when griseofulvin is combined with Efonidipine.


The risk or severity of adverse effects can be increased when barnidipine is combined with sotalol.


The risk or severity of adverse effects can be increased when griseofulvin is combined with manidipine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Olopatadine.


The risk or severity of adverse effects can be increased when quetiapine is combined with clonazepam.


The risk or severity of adverse effects can be increased when clozapine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when halothane is combined with protriptyline.


The risk or severity of adverse effects can be increased when cocaine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with halcinonide.


The risk or severity of adverse effects can be increased when oxprenolol is combined with tetracaine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Melatonin.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with difluprednate.


The risk or severity of adverse effects can be increased when pimozide is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Escitalopram is combined with tiapride.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when quinapril is combined with epirizole.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when methadone is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with dobutamine.


The risk or severity of adverse effects can be increased when Milnacipran is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when Milnacipran is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with Enalaprilat.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with azelastine.


The risk or severity of adverse effects can be increased when lorazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with cetirizine.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with Rotigotine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when clemastine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Difenoxin.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Torasemide is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when oxazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Torasemide is combined with trandolapril.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with ketoprofen.


The risk or severity of adverse effects can be increased when PENTAERYTHRITOL TETRANITRATE is combined with Deferasirox.


The risk or severity of adverse effects can be increased when desipramine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when tacrolimus is combined with amsacrine.


The risk or severity of adverse effects can be increased when clorazepate is combined with clonidine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when nicergoline is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with butorphanol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with selegiline.


The risk or severity of adverse effects can be increased when topiramate is combined with clonazepam.


The risk or severity of adverse effects can be increased when carprofen is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when nitric oxide is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when cabergoline is combined with irbesartan.


The risk or severity of adverse effects can be increased when thiothixene is combined with halothane.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Apremilast.


The risk or severity of adverse effects can be increased when edrophonium is combined with acetylcholine.


The risk or severity of adverse effects can be increased when thiothixene is combined with thiamylal.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with mirtazapine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when thiothixene is combined with desipramine.


The risk or severity of adverse effects can be increased when procarbazine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when zopiclone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Pirlindole is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when irbesartan is combined with resveratrol.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with flunarizine.


The risk or severity of adverse effects can be increased when olanzapine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when tetracaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when memantine is combined with Cevimeline.


The risk or severity of adverse effects can be increased when budesonide is combined with galanthamine.


The risk or severity of adverse effects can be increased when budesonide is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when mitomycin C is combined with clozapine.


The risk or severity of adverse effects can be increased when pergolide is combined with caffeine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when niflumic acid is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Nepafenac.


The risk or severity of adverse effects can be increased when quetiapine is combined with Butethal.


The risk or severity of adverse effects can be increased when ibuprofen is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with thiopental.


The risk or severity of adverse effects can be increased when ciprofloxacin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Melatonin is combined with clonazepam.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with equilin.


The risk or severity of adverse effects can be increased when pentoxifylline is combined with salicylic acid.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Perospirone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with trandolapril.


The risk or severity of adverse effects can be increased when thioridazine is combined with scopolamine.


The risk or severity of adverse effects can be increased when procarbazine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when methadone is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with cilazapril.


The risk or severity of adverse effects can be increased when furosemide is combined with papaverine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with galanthamine.


The risk or severity of adverse effects can be increased when naratriptan is combined with Asenapine.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when rizatriptan is combined with selegiline.


The risk or severity of adverse effects can be increased when DALFOPRISTIN is combined with atorvastatin.


The risk or severity of adverse effects can be increased when selegiline is combined with Indacaterol.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with norfloxacin.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when dobutamine is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when cilnidipine is combined with atenolol.


The risk or severity of adverse effects can be increased when celecoxib is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Vandetanib.


The risk or severity of adverse effects can be increased when atenolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when thiothixene is combined with clemastine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when meprobamate is combined with Paliperidone.


The risk or severity of adverse effects can be increased when carprofen is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Sitaxsentan.


The risk or severity of adverse effects can be increased when methenamine is combined with sulfacetamide.


The risk or severity of adverse effects can be increased when nadolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with dantrolene.


The risk or severity of adverse effects can be increased when ethotoin is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nitrendipine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when nitrendipine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Telmisartan is combined with salicylamide.


The risk or severity of adverse effects can be increased when Fosphenytoin is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when nitrendipine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Propacetamol is combined with formestane.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with maprotiline.


The risk or severity of adverse effects can be increased when Talniflumate is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when fenbufen is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when Clofarabine is combined with losartan.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when Olsalazine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when rapamycin is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with flumethasone.


The risk or severity of adverse effects can be increased when Tramadol is combined with potassium ion.


The risk or severity of adverse effects can be increased when ethanol is combined with Amfepramone.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with droxidopa.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when epirizole is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when olanzapine is combined with halothane.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Olsalazine.


The risk or severity of adverse effects can be increased when midazolam is combined with etizolam.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with trimipramine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when levodopa is combined with bupropion.


The risk or severity of adverse effects can be increased when Telmisartan is combined with fosinopril.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with mianserin.


The risk or severity of adverse effects can be increased when promazine is combined with thiamylal.


The risk or severity of adverse effects can be increased when amobarbital is combined with Etidocaine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with prilocaine.


The risk or severity of adverse effects can be increased when cabergoline is combined with Perospirone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with isoflurane.


The risk or severity of adverse effects can be increased when THYMOL is combined with nimodipine.


The risk or severity of adverse effects can be increased when buprenorphine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Masoprocol is combined with flunisolide.


The risk or severity of adverse effects can be increased when amitriptyline is combined with maprotiline.


The risk or severity of adverse effects can be increased when methadone is combined with doxepin.


The risk or severity of adverse effects can be increased when sulpiride is combined with ouabain.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when prazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when doxazosin is combined with captopril.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when diflunisal is combined with dexamethasone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when phentolamine is combined with thalidomide.


The risk or severity of adverse effects can be increased when Remoxipride is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when resveratrol is combined with loteprednol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when nortriptyline is combined with terbutaline.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with tetracycline.


The risk or severity of adverse effects can be increased when nitrazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with vinblastine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Iobenguane.


The risk or severity of adverse effects can be increased when haloperidol is combined with scopolamine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with minoxidil.


The risk or severity of adverse effects can be increased when proparacaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when diazepam is combined with dibucaine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with fosinopril.


The risk or severity of adverse effects can be increased when Carbetocin is combined with methazolamide.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with levodopa.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Eplerenone.


The risk or severity of adverse effects can be increased when sulpiride is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Carbetocin is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when nefazodone is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with estriol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with carprofen.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Carbetocin is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Lurasidone is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with QUINESTROL.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when methylphenidate is combined with trimipramine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with tetracaine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with isoniazid.


The risk or severity of adverse effects can be increased when haloperidol is combined with Agomelatine.


The risk or severity of adverse effects can be increased when topiramate is combined with flunarizine.


The risk or severity of adverse effects can be increased when oxymetholone is combined with atorvastatin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with meclizine.


The risk or severity of adverse effects can be increased when topiramate is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when trandolapril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when haloperidol is combined with Etomidate.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when methysergide is combined with nitric oxide.


The risk or severity of adverse effects can be increased when LISURIDE is combined with atorvastatin.


The risk or severity of adverse effects can be increased when efavirenz is combined with scopolamine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Apremilast.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with oxymorphone.


The risk or severity of adverse effects can be increased when amcinonide is combined with decamethonium.


The risk or severity of adverse effects can be increased when trazodone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when trazodone is combined with amoxapine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when thalidomide is combined with venlafaxine.


The risk or severity of adverse effects can be increased when ketamine is combined with HEROIN.


The risk or severity of adverse effects can be increased when methylergonovine is combined with paramethasone.


The risk or severity of adverse effects can be increased when resveratrol is combined with medrysone.


The risk or severity of adverse effects can be increased when ethotoin is combined with paroxetine.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Rotigotine.


The risk or severity of adverse effects can be increased when levorphanol is combined with triflupromazine.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when lorazepam is combined with codeine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Asenapine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when flurazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with danazol.


The risk or severity of adverse effects can be increased when Propiverine is combined with methadone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when perphenazine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with pramipexole.


The risk or severity of adverse effects can be increased when secobarbital is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when PERHEXILINE is combined with simvastatin.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Alvimopan.


The risk or severity of adverse effects can be increased when promazine is combined with Asenapine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Fospropofol.


The risk or severity of adverse effects can be increased when fosinopril is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Pipamperone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when fosinopril is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Paliperidone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when nalidixic acid is combined with melphalan.


The risk or severity of adverse effects can be increased when aspirin is combined with flunisolide.


The risk or severity of adverse effects can be increased when butabarbital is combined with cetirizine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with propoxyphene.


The risk or severity of adverse effects can be increased when pentobarbital is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with dyclonine.


The risk or severity of adverse effects can be increased when chloroquine is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when Torasemide is combined with deslanoside.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with mesoridazine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with zotepine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Nepafenac.


The risk or severity of adverse effects can be increased when loxapine is combined with clorazepate.


The risk or severity of adverse effects can be increased when quinidine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Retigabine.


The risk or severity of adverse effects can be increased when loxapine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when penbutolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when loxapine is combined with efavirenz.


The risk or severity of adverse effects can be increased when bromocriptine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when clidinium is combined with vigabatrin.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with galanthamine.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when ketorolac is combined with Icatibant.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when cisapride is combined with ethanol.


The risk or severity of adverse effects can be increased when gabapentin is combined with sertraline.


The risk or severity of adverse effects can be increased when quazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when mesoridazine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when tolazamide is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when etizolam is combined with sertraline.


The risk or severity of adverse effects can be increased when primidone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with topiramate.


The risk or severity of adverse effects can be increased when haloperidol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when loxapine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when flurazepam is combined with olanzapine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with prednisone.


The risk or severity of adverse effects can be increased when phenobarbital is combined with tiapride.


The risk or severity of adverse effects can be increased when Milnacipran is combined with ACENOCOUMAROL.


The risk or severity of adverse effects can be increased when cilnidipine is combined with MOXONIDINE.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with MEPHENTERMINE.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with dipyridamole.


The risk or severity of adverse effects can be increased when trandolapril is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when fenbufen is combined with DESONIDE.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when levorphanol is combined with rasagiline.


The risk or severity of adverse effects can be increased when ethotoin is combined with nefazodone.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when morphine is combined with potassium ion.


The risk or severity of adverse effects can be increased when loxapine is combined with Butethal.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with thioridazine.


The risk or severity of adverse effects can be increased when cyclophosphamide is combined with leflunomide.


The risk or severity of adverse effects can be increased when morphine is combined with cilazapril.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with sertraline.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with selegiline.


The risk or severity of adverse effects can be increased when Naftifine is combined with flunarizine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with paramethasone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with DESONIDE.


The risk or severity of adverse effects can be increased when bifonazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when actinomycin D is combined with leflunomide.


The risk or severity of adverse effects can be increased when propranolol is combined with papaverine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when benztropine is combined with tolterodine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when procaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with scopolamine.


The risk or severity of adverse effects can be increased when metolazone is combined with enalapril.


The risk or severity of adverse effects can be increased when metaproterenol is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when propofol is combined with Torasemide.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with betamethasone.


The risk or severity of adverse effects can be increased when nicotinic acid is combined with lovastatin.


The risk or severity of adverse effects can be increased when mesalamine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when LISURIDE is combined with amprenavir.


The risk or severity of adverse effects can be increased when LISURIDE is combined with methazolamide.


The risk or severity of adverse effects can be increased when halothane is combined with Flibanserin.


The risk or severity of adverse effects can be increased when codeine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when codeine is combined with oxazepam.


The risk or severity of adverse effects can be increased when codeine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when disulfiram is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with carprofen.


The risk or severity of adverse effects can be increased when nitric oxide is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when reserpine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when griseofulvin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when mefloquine is combined with pilocarpine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with fenoldopam.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when pancuronium is combined with morphine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with maprotiline.


The risk or severity of adverse effects can be increased when flurazepam is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with MELPERONE.


The risk or severity of adverse effects can be increased when ketorolac is combined with salicylamide.


The risk or severity of adverse effects can be increased when leflunomide is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when amoxapine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Normethadone is combined with Mersalyl.


The risk or severity of adverse effects can be increased when butabarbital is combined with triprolidine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with metoclopramide.


The risk or severity of adverse effects can be increased when leflunomide is combined with amcinonide.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with clidinium.


The risk or severity of adverse effects can be increased when Asenapine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Sacubitril.


The risk or severity of adverse effects can be increased when amiodarone is combined with spironolactone.


The risk or severity of adverse effects can be increased when buspirone is combined with linezolid.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with zotepine.


The risk or severity of adverse effects can be increased when sertraline is combined with atorvastatin.


The risk or severity of adverse effects can be increased when amobarbital is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when proparacaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when amobarbital is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when meperidine is combined with metoclopramide.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when ramipril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with vigabatrin.


The risk or severity of adverse effects can be increased when procarbazine is combined with terbutaline.


The risk or severity of adverse effects can be increased when Salsalate is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Pregabalin.


The risk or severity of adverse effects can be increased when resveratrol is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when ketoprofen is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when Sacubitril is combined with salicylamide.


The risk or severity of adverse effects can be increased when thiamylal is combined with sertraline.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when triazolam is combined with tiagabine.


The risk or severity of adverse effects can be increased when triazolam is combined with cocaine.


The risk or severity of adverse effects can be increased when chloroquine is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when D-mannitol is combined with nadolol.


The risk or severity of adverse effects can be increased when Asenapine is combined with dyclonine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with loteprednol.


The risk or severity of adverse effects can be increased when Asenapine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when triazolam is combined with zonisamide.


The risk or severity of adverse effects can be increased when Icatibant is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when reserpine is combined with glutethimide.


The risk or severity of adverse effects can be increased when equilin is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with etizolam.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with clopidogrel.


The risk or severity of adverse effects can be increased when MELPERONE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when equilin is combined with donepezil.


The risk or severity of adverse effects can be increased when oxymorphone is combined with baclofen.


The risk or severity of adverse effects can be increased when ondansetron is combined with Pipamperone.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when benzphetamine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when dibucaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with clidinium.


The risk or severity of adverse effects can be increased when meclizine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when amifostine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Etomidate is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Torasemide.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with prednisone.


The risk or severity of adverse effects can be increased when meperidine is combined with pentazocine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with protriptyline.


The risk or severity of adverse effects can be increased when Melatonin is combined with Pipamperone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with cetirizine.


The risk or severity of adverse effects can be increased when nitrendipine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when procyclidine is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when prazosin is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Lurasidone.


The risk or severity of adverse effects can be increased when amobarbital is combined with glutethimide.


The risk or severity of adverse effects can be increased when epirizole is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when etodolac is combined with alclometasone.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with hydralazine.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with codeine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with quinapril.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with bumetanide.


The risk or severity of adverse effects can be increased when baclofen is combined with dantrolene.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with tetracaine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when LEVOBUNOLOL is combined with pilocarpine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when valsartan is combined with fosinopril.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with benzocaine.


The risk or severity of adverse effects can be increased when Asenapine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when risperidone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with captopril.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Eprosartan.


The risk or severity of adverse effects can be increased when isoflurane is combined with imipramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with prazosin.


The risk or severity of adverse effects can be increased when rasagiline is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with paroxetine.


The risk or severity of adverse effects can be increased when risperidone is combined with quazepam.


The risk or severity of adverse effects can be increased when risperidone is combined with prazepam.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with maprotiline.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with mesoridazine.


The risk or severity of adverse effects can be increased when sertraline is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when methylene blue is combined with isoproterenol.


The risk or severity of adverse effects can be increased when methadone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with methyldopa.


The risk or severity of adverse effects can be increased when flumethasone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when methylene blue is combined with olanzapine.


The risk or severity of adverse effects can be increased when Tavaborole is combined with flunarizine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with phenytoin.


The risk or severity of adverse effects can be increased when oxycodone is combined with trimipramine.


The risk or severity of adverse effects can be increased when fosinopril is combined with chloroquine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when fosinopril is combined with sulindac.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with nalbuphine.


The risk or severity of adverse effects can be increased when Lacidipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when procaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when benzocaine is combined with clonidine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when etodolac is combined with diflunisal.


The risk or severity of adverse effects can be increased when temazepam is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when maprotiline is combined with felbamate.


The risk or severity of adverse effects can be increased when sumatriptan is combined with clozapine.


The risk or severity of adverse effects can be increased when risperidone is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Trospium is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when clorazepate is combined with Butethal.


The risk or severity of adverse effects can be increased when risperidone is combined with baclofen.


The risk or severity of adverse effects can be increased when clorazepate is combined with lithium ion.


The risk or severity of adverse effects can be increased when amisulpride is combined with tiagabine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with tizanidine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with glutethimide.


The risk or severity of adverse effects can be increased when apraclonidine is combined with papaverine.


The risk or severity of adverse effects can be increased when Lenalidomide is combined with clozapine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with levodopa.


The risk or severity of adverse effects can be increased when ondansetron is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when carbamazepine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with brotizolam.


The risk or severity of adverse effects can be increased when Normethadone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with gabapentin.


The risk or severity of adverse effects can be increased when diltiazem is combined with prazosin.


The risk or severity of adverse effects can be increased when enalapril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when doxepin is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when Bortezomib is combined with captopril.


The risk or severity of adverse effects can be increased when trandolapril is combined with celecoxib.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Lanreotide.


The risk or severity of adverse effects can be increased when captopril is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when nystatin is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with pimozide.


The risk or severity of adverse effects can be increased when sumatriptan is combined with sertraline.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with salicylamide.


The risk or severity of adverse effects can be increased when loxapine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when isradipine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with clomipramine.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with fluoxetine.


The risk or severity of adverse effects can be increased when amoxapine is combined with terbutaline.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with duloxetine.


The risk or severity of adverse effects can be increased when felbamate is combined with Ramelteon.


The risk or severity of adverse effects can be increased when moclobemide is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when ATROPINE is combined with hydromorphone.


The risk or severity of adverse effects can be increased when clonidine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when amitriptyline is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when flurazepam is combined with perphenazine.


The risk or severity of adverse effects can be increased when ketamine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when pergolide is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when pergolide is combined with azelastine.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when pergolide is combined with acetazolamide.


The risk or severity of adverse effects can be increased when sulpiride is combined with felbamate.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Escitalopram.


The risk or severity of adverse effects can be increased when tretinoin is combined with ramipril.


The risk or severity of adverse effects can be increased when Almotriptan is combined with moclobemide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Pramocaine.


The risk or severity of adverse effects can be increased when prilocaine is combined with clidinium.


The risk or severity of adverse effects can be increased when linezolid is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when linezolid is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when clomipramine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when doxazosin is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when linezolid is combined with metoclopramide.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when clonidine is combined with dantrolene.


The risk or severity of adverse effects can be increased when pentazocine is combined with HEROIN.


The risk or severity of adverse effects can be increased when risperidone is combined with felbamate.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with clidinium.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when oxazepam is combined with prilocaine.


The risk or severity of adverse effects can be increased when oxazepam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Salsalate.


The risk or severity of adverse effects can be increased when midazolam is combined with felbamate.


The risk or severity of adverse effects can be increased when morniflumate is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when citalopram is combined with Almotriptan.


The risk or severity of adverse effects can be increased when cerulenin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when thiothixene is combined with clonidine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when morniflumate is combined with Salsalate.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with zonisamide.


The risk or severity of adverse effects can be increased when triazolam is combined with thiothixene.


The risk or severity of adverse effects can be increased when ramipril is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when isradipine is combined with Olmesartan.


The risk or severity of adverse effects can be increased when ramipril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with triflupromazine.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with tiagabine.


The risk or severity of adverse effects can be increased when pentazocine is combined with tiapride.


The risk or severity of adverse effects can be increased when Butoconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with etizolam.


The risk or severity of adverse effects can be increased when Aclidinium is combined with Mirabegron.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Asenapine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when clozapine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when citalopram is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when clozapine is combined with spironolactone.


The risk or severity of adverse effects can be increased when clozapine is combined with triprolidine.


The risk or severity of adverse effects can be increased when pergolide is combined with Sorafenib.


The risk or severity of adverse effects can be increased when pergolide is combined with progesterone.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when tolmetin is combined with epirizole.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when amoxapine is combined with Retigabine.


The risk or severity of adverse effects can be increased when Vecuronium is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Pentolinium.


The risk or severity of adverse effects can be increased when estazolam is combined with ketamine.


The risk or severity of adverse effects can be increased when mepivacaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when thiamylal is combined with Normethadone.


The risk or severity of adverse effects can be increased when HEROIN is combined with Alvimopan.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when thioridazine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when quazepam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Retigabine.


The risk or severity of adverse effects can be increased when tolmetin is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when etodolac is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with trimipramine.


The risk or severity of adverse effects can be increased when citalopram is combined with Paliperidone.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Eprosartan is combined with hydralazine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when midazolam is combined with clozapine.


The risk or severity of adverse effects can be increased when ethopropazine is combined with dicyclomine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Clevidipine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when ondansetron is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with desipramine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with baclofen.


The risk or severity of adverse effects can be increased when Remoxipride is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with etoposide.


The risk or severity of adverse effects can be increased when halcinonide is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when triazolam is combined with clonidine.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with carvedilol.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Retigabine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with sumatriptan.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with terbutaline.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when ipratropium is combined with propantheline.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with mepivacaine.


The risk or severity of adverse effects can be increased when cimetidine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Tolcapone is combined with desipramine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with oxprenolol.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Bretylium.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with donepezil.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with tizanidine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with furazolidone.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when tenoxicam is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with methyldopa.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with dexamethasone.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with captopril.


The risk or severity of adverse effects can be increased when buspirone is combined with diazepam.


The risk or severity of adverse effects can be increased when Butethal is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when reserpine is combined with clonidine.


The risk or severity of adverse effects can be increased when perphenazine is combined with dantrolene.


The risk or severity of adverse effects can be increased when diflunisal is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with clidinium.


The risk or severity of adverse effects can be increased when tenoxicam is combined with fenoprofen.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when meprobamate is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Escitalopram is combined with sulpiride.


The risk or severity of adverse effects can be increased when tetracaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when meprobamate is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Valganciclovir is combined with lamivudine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with felbamate.


The risk or severity of adverse effects can be increased when buspirone is combined with oxymorphone.


The risk or severity of adverse effects can be increased when quetiapine is combined with topiramate.


The risk or severity of adverse effects can be increased when buspirone is combined with zopiclone.


The risk or severity of adverse effects can be increased when nitric oxide is combined with benzocaine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with PRIMAQUINE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when amphotericin b is combined with mecamylamine.


The risk or severity of adverse effects can be increased when glutethimide is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when spironolactone is combined with hydralazine.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Masoprocol.


The risk or severity of adverse effects can be increased when Ramelteon is combined with clomipramine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when clozapine is combined with Asenapine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with loratadine.


The risk or severity of adverse effects can be increased when prazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when prazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with atenolol.


The risk or severity of adverse effects can be increased when metaproterenol is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when methysergide is combined with dimethyl sulfoxide.


The risk or severity of adverse effects can be increased when tizanidine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when methadone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with quetiapine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with nimesulide.


The risk or severity of adverse effects can be increased when methadone is combined with rizatriptan.


The risk or severity of adverse effects can be increased when methysergide is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with apraclonidine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Tadalafil.


The risk or severity of adverse effects can be increased when alprazolam is combined with ethotoin.


The risk or severity of adverse effects can be increased when alprazolam is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when tetracaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with methyldopa.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with triflupromazine.


The risk or severity of adverse effects can be increased when tizanidine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with metoclopramide.